A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4.1K citations · Full text

Medicine, Oncology, Pathology +14

Prognostic markers in triple‐negative breast cancer

Emad A. Rakha, Maysa E. El‐Sayed, Andrew R. Green et al. · Cancer · 2006 · 1.3K citations

Medicine, Oncology, Breast Oncology +16

Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation

Marie-Liesse Asselin-Labat, Holly E. Barker, Richard M. Thomas et al. · Nature Cell Biology · 2006 · 838 citations

Life Sciences, Developmental Biology, Molecular Genetics +16

Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

Tiffany A. Traina, Kathy D. Miller, Denise A. Yardley et al. · Journal of Clinical Oncology · 2018 · 519 citations · Full text

Medicine, Oncology, Pharmacology +17

Sox10: A Pan-Schwannian and Melanocytic Marker

Daisuke Nonaka, Luis Chiriboga, Brian P. Rubin · The American Journal of Surgical Pathology · 2008 · 400 citations

Medicine, Oncology, Pathology +17